Raymond James & Associates’s AdaptHealth AHCO Stock Holding History

Raymond James & Associates’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$225K	Buy	20,002 +64	+0.3%	+$680	﹤0.01%	3569
2024 Q2	$199K	Buy	19,938 +3,959	+25%	+$40.2K	﹤0.01%	3604
2024 Q1	$184K	Buy	15,979 +194	+1%	+$1.65K	﹤0.01%	3637
2023 Q4	$115K	Buy	15,785 +4,740	+43%	+$37.4K	﹤0.01%	3628
2023 Q3	$101K	Buy	+11,045	New	+$132K	﹤0.01%	3596
2022 Q2	–	Sell	-57,110	Closed	-$915K	–	4022
2022 Q1	$915K	Buy	57,110 +37,271	+188%	+$670K	﹤0.01%	2662
2021 Q4	$485K	Buy	19,839 +85	+0.4%	+$2K	﹤0.01%	3100
2021 Q3	$460K	Buy	+19,754	New	+$478K	﹤0.01%	3125
2021 Q2	–	Sell	-12,630	Closed	-$464K	–	4086
2021 Q1	$464K	Buy	+12,630	New	+$446K	﹤0.01%	3073

Other funds holding AHCO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OCA

OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Raymond James & Associates's AHCO Position: Q3 2024 in Review

Raymond James & Associates increased its AdaptHealth (AHCO) stake by 0.32% in Q3 2024, buying an estimated $680 and bringing the position to 20,002 shares worth $225K. The position accounts for ﹤0.01% of the portfolio, ranked #3569.

Raymond James & Associates first reported a position in AHCO in Q1 2021 and has held it in 9 quarters since. The position peaked at $915K in Q1 2022. 217 funds tracked by Wall St. Rank hold AHCO as of Q3 2024.

Raymond James & Associates held 20,002 shares of AdaptHealth worth $225K as of Q3 2024.
Raymond James & Associates bought 64 AdaptHealth shares in Q3 2024, an estimated $680.
AdaptHealth made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3569 holding.
Raymond James & Associates first reported a position in AdaptHealth in Q1 2021 and has held it in 9 quarters since.
Raymond James & Associates's AdaptHealth position peaked at $915K in Q1 2022.
217 funds tracked by Wall St. Rank held AdaptHealth as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.